About SurgicEye® GmbH: SurgicEye® GmbH is a pioneer in intra-operative 3-D imaging for surgical navigation. The company develops breakthrough tools in the fight against cancer. The declipse®SPECT from SurgicEye® is the world’s first FDA and CE certified product for intra-operative three dimensional visualization of radio labeled tissues and allows the detection, localization and guided biopsy of sentinel lymph…
SurgicEye GmbH will present its Solutions for Nuclear Medicine Guided Therapies during the annual meeting of the European Society of Nuclear Medicine (EANM) including the 3D surgical imaging for support in radio-guided surgery as well as its dose planing and dose monitoring solutions for radionuclide therapy Additionally, a new solution for treatment planning is presented. DosePlan – smart and time-saving dosimetry Visit us in the Pavilion – Hall X2, Booth No. 238 for a product demonstration or a refreshing drink while having a break.
What clinicians say
- Prof. Dr. Marion KiechleDirector of the Women’s Hospital Klinikum rechts der Isar Munich, GermanyThe declipse®SPECT technology and its intraoperative use for navigated sentinel lymph node dissection enables safer surgeries, and less invasive procedures. This can ensure a high quality outcome for every individual patient.
- Dr. Omgo E. NiewegSurgeon, The Netherlands Cancer Institute Amsterdam, the NetherlandsThe innovative 3D declipseSPECT technology may make the sentinel node biopsy easier and more reliable. New technologies like 3D declipseSPECT will also open up lymphatic mapping to additional cancer types in locations with a more intricate anatomy and cancer types with more complex lymph drainage.
- Prof. Dr. René HornungHead of Department of Gynecology Kantonsspital St. Gallen, SwitzerlandThe 3D declipse®SPECT Laparoscopy technology opens new horizons to minimally invasive surgery in gynecologic oncology. Sentinel lymph node biopsy during laparoscopic procedures seems to be easily feasible and may in the near future become standard of care for cervical and endometrial cancers.
- Dr. Sergi Vidal SicartNuclear Medicine Specialist, Hospital Clínic Barcelona, SpainThe 3D declipseSPECT presents a potential tool in refining the excision margins of tumor in the ROLL technique. The possibility to observe the harvested tissue and the tracer activity within it offers a realistic view of the surgical procedure suited for the operating room.